Published in Mar Drugs on October 18, 2012
Sonorensin: an antimicrobial peptide, belonging to the heterocycloanthracin subfamily of bacteriocins, from a new marine isolate, Bacillus sonorensis MT93. Appl Environ Microbiol (2014) 0.88
Emerging strategies and integrated systems microbiology technologies for biodiscovery of marine bioactive compounds. Mar Drugs (2014) 0.87
Evaluation of the efficacy and safety of a marine-derived Bacillus strain for use as an in-feed probiotic for newly weaned pigs. PLoS One (2014) 0.78
In vitro assessment of marine Bacillus for use as livestock probiotics. Mar Drugs (2014) 0.76
Marine Pseudovibrio sp. as a novel source of antimicrobials. Mar Drugs (2014) 0.76
Antimicrobial Activities of Bacteria Associated with the Brown Alga Padina pavonica. Front Microbiol (2016) 0.75
Antibacterial Activities of Bacteria Isolated from the Marine Sponges Isodictya compressa and Higginsia bidentifera Collected from Algoa Bay, South Africa. Mar Drugs (2017) 0.75
Antimicrobial Activity of Marine Bacterial Symbionts Retrieved from Shallow Water Hydrothermal Vents. Mar Biotechnol (NY) (2016) 0.75
Basic local alignment search tool. J Mol Biol (1990) 659.07
Bacteriocins: developing innate immunity for food. Nat Rev Microbiol (2005) 5.77
An application in cheddar cheese manufacture for a strain of Lactococcus lactis producing a novel broad-spectrum bacteriocin, lacticin 3147. Appl Environ Microbiol (1996) 2.45
Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins. Appl Environ Microbiol (2009) 1.68
Diversity and applications of Bacillus bacteriocins. FEMS Microbiol Rev (2011) 1.38
Molecular and genetic characterization of a novel nisin variant produced by Streptococcus uberis. Appl Environ Microbiol (2006) 1.35
Isolation and analysis of bacteria with antimicrobial activities from the marine sponge Haliclona simulans collected from Irish waters. Mar Biotechnol (NY) (2008) 1.30
Antibiotic activity of epiphytic bacteria isolated from intertidal seaweeds. Microb Ecol (1985) 1.22
Heterologous expression, biosynthesis, and mutagenesis of type II lantibiotics from Bacillus licheniformis in Escherichia coli. Chem Biol (2011) 1.20
Streptococcus rattus strain BHT produces both a class I two-component lantibiotic and a class II bacteriocin. FEMS Microbiol Lett (2005) 1.19
Cloning, sequencing and production of the lantibiotic mersacidin. FEMS Microbiol Lett (1995) 1.15
Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13. PLoS One (2009) 1.14
Pumilicin 4, a novel bacteriocin with anti-MRSA and anti-VRE activity produced by newly isolated bacteria Bacillus pumilus strain WAPB4. Curr Microbiol (2007) 1.13
Diversity of antibiotic-active bacteria associated with the brown alga Laminaria saccharina from the Baltic Sea. Mar Biotechnol (NY) (2008) 1.13
Novel anti-infective compounds from marine bacteria. Mar Drugs (2010) 1.08
Isolation, structure elucidation, and synergistic antibacterial activity of a novel two-component lantibiotic lichenicidin from Bacillus licheniformis VK21. Biochemistry (2010) 1.07
Development of novel drugs from marine surface associated microorganisms. Mar Drugs (2010) 1.06
Diversity and bioactive potential of endospore-forming bacteria cultured from the marine sponge Haliclona simulans. J Appl Microbiol (2011) 1.04
Bacteriocin-like substance production by Bacillus licheniformis strain P40. Lett Appl Microbiol (2004) 0.98
Antimicrobial activity observed among cultured marine epiphytic bacteria reflects their potential as a source of new drugs. FEMS Microbiol Ecol (2009) 0.98
Characterization of the structural gene encoding nisin F, a new lantibiotic produced by a Lactococcus lactis subsp. lactis isolate from freshwater catfish (Clarias gariepinus). Appl Environ Microbiol (2007) 0.95
Characterization of enterocin- and salivaricin-producing lactic acid bacteria from the mammalian gastrointestinal tract. FEMS Microbiol Lett (2008) 0.95
Bacteriocin as weapons in the marine animal-associated bacteria warfare: inventory and potential applications as an aquaculture probiotic. Mar Drugs (2010) 0.93
Purification and partial characterization of bacillocin 490, a novel bacteriocin produced by a thermophilic strain of Bacillus licheniformis. Microb Cell Fact (2002) 0.92
Characterization of lactosporin, a novel antimicrobial protein produced by Bacillus coagulans ATCC 7050. J Appl Microbiol (2009) 0.90
Purification and characterization of a bacteriocin-like compound (Lichenin) produced anaerobically by Bacillus licheniformis isolated from water buffalo. J Appl Microbiol (2001) 0.88
Purification and characterization of a new peptide antibiotic produced by a thermotolerant Bacillus licheniformis strain. Biotechnol Lett (2004) 0.88
Genotyping of starter cultures of Bacillus subtilis and Bacillus pumilus for fermentation of African locust bean (Parkia biglobosa) to produce Soumbala. Int J Food Microbiol (2004) 0.86
Lantibiotics, class I bacteriocins from the genus Bacillus. J Microbiol Biotechnol (2011) 0.86
Production of antimicrobial substances by Bacillus subtilis LFE-1, B. firmus HO-1 and B. licheniformis T6-5 isolated from an oil reservoir in Brazil. J Appl Microbiol (2005) 0.84
Recovery and characterization of a 30.7-kDa protein from Bacillus licheniformis associated with inhibitory activity against methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and Listeria monocytogenes. Mar Biotechnol (NY) (2006) 0.82
Production and partial characterization of bacteriocin-like pepitdes by Bacillus licheniformis ZJU12. Microbiol Res (2006) 0.81
Real-time PCR detection of Fe-type nitrile hydratase genes from environmental isolates suggests horizontal gene transfer between multiple genera. Antonie Van Leeuwenhoek (2010) 0.79
Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep (2013) 5.38
Potential impact of antiviral drug use during influenza pandemic. Emerg Infect Dis (2005) 5.35
Elements of morphology: standard terminology for the ear. Am J Med Genet A (2009) 2.64
Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut (2012) 2.24
Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon. Proc Natl Acad Sci U S A (2010) 2.11
Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proc Natl Acad Sci U S A (2010) 1.89
High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother (2012) 1.69
Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins. Appl Environ Microbiol (2009) 1.68
The generation of nisin variants with enhanced activity against specific gram-positive pathogens. Mol Microbiol (2008) 1.62
Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity. Biochemistry (2004) 1.61
Bacteriocin production: a probiotic trait? Appl Environ Microbiol (2011) 1.57
Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol (2013) 1.56
The gut microbiota and its relationship to diet and obesity: new insights. Gut Microbes (2012) 1.52
Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design. Mol Microbiol (2006) 1.45
Streptolysin S-like virulence factors: the continuing sagA. Nat Rev Microbiol (2011) 1.42
Computer therapy compared with usual care for people with long-standing aphasia poststroke: a pilot randomized controlled trial. Stroke (2012) 1.40
Specificity of cytoplasmic dynein subunits in discrete membrane-trafficking steps. Mol Biol Cell (2009) 1.39
A five-strain probiotic combination reduces pathogen shedding and alleviates disease signs in pigs challenged with Salmonella enterica Serovar Typhimurium. Appl Environ Microbiol (2007) 1.38
Antimicrobial activity of lacticin 3,147 against clinical Clostridium difficile strains. J Med Microbiol (2007) 1.33
Isolation and analysis of bacteria with antimicrobial activities from the marine sponge Haliclona simulans collected from Irish waters. Mar Biotechnol (NY) (2008) 1.30
Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations. Antimicrob Agents Chemother (2005) 1.30
Discovery of medically significant lantibiotics. Curr Drug Discov Technol (2009) 1.29
Prebiotics from marine macroalgae for human and animal health applications. Mar Drugs (2010) 1.28
Mutations in the BRWD3 gene cause X-linked mental retardation associated with macrocephaly. Am J Hum Genet (2007) 1.26
Two-peptide lantibiotics: a medical perspective. Mini Rev Med Chem (2007) 1.26
Composition of the early intestinal microbiota: knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps. Gut Microbes (2012) 1.23
High-throughput sequencing for detection of subpopulations of bacteria not previously associated with artisanal cheeses. Appl Environ Microbiol (2012) 1.23
Lantibiotic immunity. Curr Protein Pept Sci (2008) 1.22
The microbial eukaryote Blastocystis is a prevalent and diverse member of the healthy human gut microbiota. FEMS Microbiol Ecol (2014) 1.21
Contribution of penicillin-binding protein homologs to antibiotic resistance, cell morphology, and virulence of Listeria monocytogenes EGDe. Antimicrob Agents Chemother (2006) 1.21
Identification of a novel two-peptide lantibiotic, haloduracin, produced by the alkaliphile Bacillus halodurans C-125. FEMS Microbiol Lett (2007) 1.21
Posttranslational conversion of L-serines to D-alanines is vital for optimal production and activity of the lantibiotic lacticin 3147. Proc Natl Acad Sci U S A (2005) 1.20
Microneedle mediated delivery of nanoparticles into human skin. Int J Pharm (2008) 1.20
A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species. J Antimicrob Chemother (2009) 1.20
Relative ability of orally administered Lactobacillus murinus to predominate and persist in the porcine gastrointestinal tract. Appl Environ Microbiol (2004) 1.18
The dawning of a 'Golden era' in lantibiotic bioengineering. Mol Microbiol (2010) 1.18
The complex microbiota of raw milk. FEMS Microbiol Rev (2013) 1.18
Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V. Microb Biotechnol (2010) 1.14
Production of the Bsa lantibiotic by community-acquired Staphylococcus aureus strains. J Bacteriol (2009) 1.13
Predominance of a bacteriocin-producing Lactobacillus salivarius component of a five-strain probiotic in the porcine ileum and effects on host immune phenotype. FEMS Microbiol Ecol (2008) 1.12
Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid. Int J Food Microbiol (2011) 1.11
Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters. Psychopharmacology (Berl) (2012) 1.09
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics. Antimicrob Agents Chemother (2010) 1.09
Bioengineered nisin A derivatives with enhanced activity against both Gram positive and Gram negative pathogens. PLoS One (2012) 1.08
Sequencing-based analysis of the bacterial and fungal composition of kefir grains and milks from multiple sources. PLoS One (2013) 1.07
TelA contributes to the innate resistance of Listeria monocytogenes to nisin and other cell wall-acting antibiotics. Antimicrob Agents Chemother (2010) 1.05
Molecular approaches to analysing the microbial composition of raw milk and raw milk cheese. Int J Food Microbiol (2011) 1.05
In silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria. BMC Genomics (2010) 1.04
Microbial composition of human appendices from patients following appendectomy. MBio (2013) 1.02
Sequence-based analysis of the bacterial and fungal compositions of multiple kombucha (tea fungus) samples. Food Microbiol (2013) 1.02
Genome mining for radical SAM protein determinants reveals multiple sactibiotic-like gene clusters. PLoS One (2011) 1.01
The microbial content of raw and pasteurized cow milk as determined by molecular approaches. J Dairy Sci (2013) 1.01
Targeting the microbiota to address diet-induced obesity: a time dependent challenge. PLoS One (2013) 1.01
Effects of short-term feeding of Bt MON810 maize on growth performance, organ morphology and function in pigs. Br J Nutr (2011) 1.00
Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147. Mol Microbiol (2009) 1.00
Effect of Lactobacillus salivarius bacteriocin Abp118 on the mouse and pig intestinal microbiota. PLoS One (2012) 1.00
Fate of transgenic DNA from orally administered Bt MON810 maize and effects on immune response and growth in pigs. PLoS One (2011) 0.99
Gut microbial diversity is reduced and is associated with colonic inflammation in a piglet model of short bowel syndrome. Gut Microbes (2013) 0.97
Antioxidative, tyrosinase inhibiting and antibacterial activities of leaf extracts from medicinal ferns. Biosci Biotechnol Biochem (2009) 0.97
Nucleic acid-based approaches to investigate microbial-related cheese quality defects. Front Microbiol (2013) 0.97
High-throughput sequence-based analysis of the bacterial composition of kefir and an associated kefir grain. FEMS Microbiol Lett (2011) 0.96
The two peptide lantibiotic lacticin 3147 acts synergistically with polymyxin to inhibit Gram negative bacteria. BMC Microbiol (2013) 0.96
Bioengineering of a Nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z. Microb Biotechnol (2010) 0.95
Real-time PCR assay to differentiate Listeriolysin S-positive and -negative strains of Listeria monocytogenes. Appl Environ Microbiol (2010) 0.95
Characterization of enterocin- and salivaricin-producing lactic acid bacteria from the mammalian gastrointestinal tract. FEMS Microbiol Lett (2008) 0.95
Contrasting effects of Bifidobacterium breve NCIMB 702258 and Bifidobacterium breve DPC 6330 on the composition of murine brain fatty acids and gut microbiota. Am J Clin Nutr (2012) 0.93
Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria. Int J Antimicrob Agents (2010) 0.93
Comparison of the principal proteins in bovine, caprine, buffalo, equine and camel milk. J Dairy Res (2012) 0.92
Saturation mutagenesis of lysine 12 leads to the identification of derivatives of nisin A with enhanced antimicrobial activity. PLoS One (2013) 0.92
The individual-specific and diverse nature of the preterm infant microbiota. Arch Dis Child Fetal Neonatal Ed (2013) 0.91
Tn6188 - a novel transposon in Listeria monocytogenes responsible for tolerance to benzalkonium chloride. PLoS One (2013) 0.91
Cu(II) binding by dried biomass of red, green and brown macroalgae. Water Res (2007) 0.90
Bacteriocin production by Bifidobacterium spp. A review. Biotechnol Adv (2013) 0.90
High-throughput sequence-based analysis of the intestinal microbiota of weanling pigs fed genetically modified MON810 maize expressing Bacillus thuringiensis Cry1Ab (Bt maize) for 31 days. Appl Environ Microbiol (2012) 0.90
Bioengineered nisin derivatives with enhanced activity in complex matrices. Microb Biotechnol (2012) 0.90
The effect of feeding Bt MON810 maize to pigs for 110 days on intestinal microbiota. PLoS One (2012) 0.90
Effects of feeding Bt MON810 maize to pigs for 110 days on peripheral immune response and digestive fate of the cry1Ab gene and truncated Bt toxin. PLoS One (2012) 0.89
Phosphorylation and membrane dissociation of the ARF exchange factor GBF1 in mitosis. Biochem J (2010) 0.89
Fate and efficacy of lacticin 3147-producing Lactococcus lactis in the mammalian gastrointestinal tract. FEMS Microbiol Ecol (2011) 0.89